WEHI-164 Cells

The WEHI-164 cell line was originally established from a fibrosarcoma that developed in a BALB/c mouse following subcutaneous injections of 3-methylcholanthrene. This cell line is derived from mesenchymal tissue and demonstrates characteristics typical of fibroblast-like cells. WEHI-164 has been a critical tool in the study of cancer, providing insights particularly in the fields of tumor immunology and the cellular mechanisms of apoptosis.

WEHI-164 cells are especially valued in research due to their responsiveness to cytokine-induced apoptosis, making them an important model for studying the interaction between cytokines and cancer cells. This sensitivity to cytokines like tumor necrosis factor (TNF) and TRAIL (TNF-related apoptosis-inducing ligand) positions the WEHI-164 cell line as a useful resource for exploring signaling pathways that mediate cell death and for screening potential anticancer therapies that could manipulate these pathways. Additionally, the cell line’s fibroblast-like properties allow for studies on cell morphology, growth characteristics, and the tumor microenvironment, providing a more comprehensive understanding of tumor dynamics and interactions within the cellular matrix.

Despite its extensive use in research, the WEHI-164 cell line exhibits several chromosomal aberrations, which is common among cells transformed by chemical carcinogenesis. These genetic instabilities are crucial for studies focused on understanding how genetic variations can influence cancer progression and response to treatments. The ongoing use of WEHI-164 in various research setups underscores its utility in advancing the knowledge of cancer biology and in the development of novel therapeutic approaches.